†Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic v.v.i., Flemingovo nam 2, Prague 6-Dejvice, 16610, Czech Republic.
§Faculty of Mathematics and Physics, Charles University in Prague, Ke Karlovu 3, Prague 2, 12116, Czech Republic.
J Med Chem. 2015 Aug 13;58(15):5950-66. doi: 10.1021/acs.jmedchem.5b00570. Epub 2015 Jul 29.
N-Methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that play a crucial role in excitatory synaptic transmission. However, the overactivation of NMDARs can lead to excitotoxic cell damage/death, and as such, they play a role in numerous neuropathological conditions. The activity of NMDARs is known to be influenced by a wide variety of allosteric modulators, including neurosteroids, which in turn makes them promising therapeutic targets. In this study, we describe a new class of neurosteroid analogues which possess structural modifications in the steroid D-ring region. These analogues were tested on recombinant GluN1/GluN2B receptors to evaluate the structure-activity relationship. Our results demonstrate that there is a strong correlation between this new structural feature and the in vitro activity, as all tested compounds were evaluated as more potent inhibitors of NMDA-induced currents (IC50 values varying from 90 nM to 5.4 μM) than the known endogeneous neurosteroid-pregnanolone sulfate (IC50 = 24.6 μM).
N-甲基-D-天冬氨酸受体(NMDARs)是谷氨酸门控离子通道,在兴奋性突触传递中发挥着关键作用。然而,NMDARs 的过度激活会导致兴奋性细胞损伤/死亡,因此它们在许多神经病理学条件中发挥作用。已知 NMDARs 的活性受多种变构调节剂的影响,包括神经甾体,这使得它们成为有前途的治疗靶点。在这项研究中,我们描述了一类具有甾体 D 环区域结构修饰的新型神经甾体类似物。这些类似物在重组 GluN1/GluN2B 受体上进行了测试,以评估结构-活性关系。我们的结果表明,这种新的结构特征与体外活性之间存在很强的相关性,因为所有测试的化合物都被评估为比已知的内源性神经甾体-孕烷醇酮硫酸盐(IC50 = 24.6 μM)更有效的 NMDA 诱导电流抑制剂(IC50 值从 90 nM 到 5.4 μM 不等)。